TradingView India.
Date, Research Firm, Action, Current, Target. Wall Street analysts weigh in with their price targets at Analyst Ratings Network. The average equity rating for PTLA stock is currently 2.70, trading closer to a bullish pattern in the stock market. View %COMPANY_NAME% PTLA investment & stock information. Wait the right signal before choosing the Market direction Technical Analysis Consideration - Hold The Market can still move between the channel lines. “Data-reactid =” 27 “> It’s nice to see that Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) stock price increases 10% in one week. Portola Pharmaceuticals Inc. NASDAQ Updated Jul 1, 2020 8:00 PM PTLA 18.03 0.04 (0.22%). PTLA Stock Quotes API Business Summary Portola Pharmaceuticals, Inc. is a biopharmaceutical company .It focuses on the development and commercialization of therapeutics for thrombosis, other hematologic disorders and inflammation. Real time Portola Pharmaceuticals (PTLA) stock price quote, stock graph, news & analysis. In the short term (2weeks), PTLA's stock price should underperform the market by -0.45%.During that period the price should oscillate between … 5,017 For more data, Barchart Premier members can download more historical data (going back to Jan. 1, 1980) and can download Intraday, Daily, Weekly, Monthly or Quarterly data on the Historical Download tab.Additional underlying chart data and study values can be downloaded using the Interactive Charts. The analysts offering 12-month price forecasts for Portola Pharmaceuticals Inc have a median tar… Compare key indexes, including Nasdaq Composite, Nasdaq-100, Dow Jones Industrial & more. Portola Pharmaceuticals (PTLA) stock is dropping late Monday afternoon as Goldman Sachs downgraded the stock and the company reported disappointing trial results last week. Stock Price Forecast. Where is Portola Pharmaceuticals stock heading? WeissLaw LLP 1500 Broadway, 16 th Floor New York, NY 10036 (212) 682-3025 (888) 593-4771 stockinfo@weisslawllp.com. 7 benefits of working from home; Jan. 26, 2021. Blog. Get the latest %COMPANY_NAME% PTI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Closing Stock Price USD 47.91: As of Date October 5, 2015: One Year Performance 73.59%: One Month Performance 5.88%: Industry Group Pharmaceuticals: Other: 52 wk. The market cap for the stock reached $1.41 billion, with 78.17 million shares outstanding and 77.67 million shares in the current float. A look at earnings from the view of macro-economists and market technicians Portola Pharmaceuticals, Inc. (PTLA) Price - Zacks.com. Ptla stock price forecast. Five strategies to maximize your sales kickoff; Jan. 26, 2021. Get the latest %COMPANY_NAME% PTLA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Engage students in your virtual classroom with Prezi … PTLA shares had a relatively better volume day versus average trading capacity of 1.96 million shares, but with a 76.88 million float and a -6.9% run over a week, it’s definitely worth keeping an eye on. The medical/dental supplies company's consensus earnings per share forecast from the 7 analysts that follow the stock is $0.54. PTLA -- USA Stock : USD 18.03 0.00 0.00% : Portola Pharmaceuticals' market value is the price at which a share of Portola Pharmaceuticals stock trades on a public exchange. Based on 7 analysts offering 12 month price targets for Portola Pharma in the last 3 months. As returns on the market increase, Portola Pharmaceuticals returns are expected to increase less than the market. It is mainly based on fundamental - (go long) Short term, technical analysis suggests that price might move up (go long) Olson noted: “PTLA reported 1Q results roughly in line with expectations, including ($1.17) GAAP EPS, matching consensus and ahead of our ($1.35) estimate. View %COMPANY_NAME% PTI investment & stock information. Stock Price Forecast for PTLA: Portola Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still. Portola Pharmaceuticals Inc stock is lower by -39.55% over the last 12 months, and the average rating from Wall Street analysts is a Buy.InvestorsObserver’s proprietary ranking system, gives PTLA stock a score of 62 out of a possible 100.. That rank is chiefly influenced by a long-term technical score of 89. Do you wonder what the value of Portola Pharmaceuticals is? The prevailing price of the company is $18.03. The one year price forecast for PTLA stock indicates that … Oppenheimer analyst Jay Olson maintained a Buy rating on Portola Pharma (PTLA – Research Report) today and set a price target of $42.The company’s shares opened today at $32.06. Price trends tend to persist, so it's worth looking at them when it comes to a share like Portola Pharmaceuticals Inc. Over the past six months, the relative strength of its shares against the market has been -33.23%. In fact, the stock price fell 53% over the period. Most stock quote data provided by BATS.